Euromonitor International's Herbal/traditional Products in Brazil report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data (2004-2009), allowing you to identify the segments driving growth. It identifies the leading firms , the leading brands and offers strategic analysis of key factors influencing the industry - be they new product developments, distribution or pricin...
More »
Search ReportLinker
The Largest Collection of Market Research Reports
» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides
From +200,000 authoritative sources
Euromonitor International's Herbal/traditional Products in Brazil report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data (2004-2009), allowing you to identify the segments driving growth. It identifies the leading firms , the leading brands and offers strategic analysis of key factors influencing the industry - be they new product developments, distribution or pricing issues. Projections to 2014 illustrate how the industry is set to change.
Product coverage:
herbal analgesics, herbal cough, cold and allergy (hayfever) remedies, herbal digestive remedies, herbal medicated skin care, herbal dietary supplements, herbal tonics/bottled nutritive drinks,, herbal child-specific vitamins and dietary supplements, herbal calming and sleeping products, herbal medicinal teas, herbal smoking cessation aids
Data coverage:
indsutry size (historic and projections ), market shares and brand shares.
Reasons to Buy This Report
* Gain in-depth understanding of the vitamins and dietary supplements market ;
* Identify areas of growth and understand key dynamics ;
* Get a full overview of the competitive landscape , the industry ’s major players and leading brands;
* Anticipate market change with 5 year forecasts .
Drug And Medication Industry in Brazil
Herbal/traditional Products in Brazil
February 2010
List of Contents and Tables
Executive Summary
Consumer Healthcare Remains Resilient Despite the Economic Slowdown
Anvisa Moves OTC Products Behind-the-counter
Pharmaceutical Market Moving Towards Consolidation
Parapharmacies/drugstores Dominate Sales of OTC Products
Further Investment From Multinational Players
Key Trends and Developments
OTC Products Moved Behind-the-counter
Anvisa Approves New Rules for Advertising and Suspends Advertising of Analgesics
Pharmaceutical Market Moving Towards Consolidation
OTC Segment Remains Resilient During Economic Slowdown
Market Indicators
Data table 1 Consumer Expenditure on Health Goods and Medical Services from 2004 to 2009
Data table 2 Life Expectancy at Birth from 2004 to 2009
Market Data
Data table 3 Sales of Consumer Health by Segment : Value from 2004 to 2009
Data table 4 Sales of Consumer Health by Segment : % Value Growth from 2004 to 2009
Data table 5 Consumer Health Market Shares by Value from 2005 to 2009
Data table 6 Consumer Health Brand Shares by Value from 2006 to 2009
Data table 7 Sales of Consumer Health by Distribution Format: % Analysis from 2004 to 2009
Data table 8 Sales of Consumer Health by Segment and Distribution Format: % Analysis 2009
Data table 9 Projection Sales of Consumer Health by Segment : Value from 2009 to 2014
Data table 10 Projection Sales of Consumer Health by Segment : % Value Growth from 2009 to 2014
Appendix
OTC Registration and Classification
De-reimbursement
Generics
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches from 2007 to 2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Aché Laboratórios Farmacêuticos SA
Strategic Direction
Key Facts
Summary 3 Aché Laboratórios Farmacêuticos SA: Key Facts
Summary 4 Aché Laboratórios Farmacêuticos SA: Operational Indicators
Company Background
Production
Summary 5 Aché Laboratórios Farmacêuticos SA: Production Statistics 2009
Competitive Positioning
Summary 6 Aché Laboratórios Farmacêuticos SA: Competitive Position 2009
Bayer (brasil) SA
Strategic Direction
Key Facts
Summary 7 Bayer SA: Key Facts
Summary 8 Bayer SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Bayer SA: Competitive Position 2009
Boehringer Ingelheim Do Brasil Química E Farmacêutica Ltda
Strategic Direction
Key Facts
Summary 10 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Key Facts
Summary 11 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Operational Indicators
Company Background
Production
Summary 12 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2009
Competitive Positioning
Summary 13 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2009
Cadbury Adams Brasil Indústria E Comércio De Produtos Alimentícios Ltda
Strategic Direction
Key Facts
Summary 14 Cadbury Adams Indústria e Comércio Alimentícios Ltda: Key Facts
Company Background
Production
Competitive Positioning
Summary 16 Cadbury Adams Indústria e Comércio Alimentícios Ltda: Competitive Position 2009
Ems SA
Strategic Direction
Key Facts
Summary 17 EMS SA: Key Facts
Summary 18 EMS SA: Operational Indicators
Company Background
Production
Summary 19 EMS SA: Production Statistics 2009
Competitive Positioning
Summary 20 EMS SA: Competitive Position 2009
Eurofarma Laboratório Ltda
Strategic Direction
Key Facts
Summary 21 Eurofarma Laboratório Ltda: Key Facts
Summary 22 Eurofarma Laboratório Ltda: Operational Indicators
Company Background
Production
Summary 23 Eurofarma Laboratório Ltda: Production Statistics 2009
Competitive Positioning
Summary 24 Eurofarma Laboratório Ltda: Competitive Position 2009
Hypermarcas SA
Strategic Direction
Key Facts
Summary 25 Hypermarcas SA: Key Facts
Summary 26 Hypermarcas SA: Operational Indicators
Company Background
Production
Summary 27 Hypermarcas SA: Production Statistics 2009
Competitive Positioning
Summary 28 Hypermarcas SA: Competitive Position 2009
Medley SA Indústria Farmacêutica
Strategic Direction
Key Facts
Summary 29 Medley SA Indústria Farmacêutica: Key Facts
Summary 30 Medley SA Indústria Farmacêutica: Operational Indicators
Company Background
Production
Summary 31 Medley SA Indústria Farmacêutica: Production Statistics 2009
Competitive Positioning
Summary 32 Medley SA Indústria Farmacêutica: Competitive Position 2009
Nycomed Pharma Ltda
Strategic Direction
Key Facts
Summary 33 Nycomed Pharma Ltda: Key Facts
Summary 34 Nycomed Pharma Ltda: Operational Indicators
Company Background
Production
Summary 35 Nycomed Pharma Ltda: Production Statistics 2009
Competitive Positioning
Summary 36 Nycomed Pharma Ltda: Competitive Position 2009
Sanofi-aventis Farmacêutica Ltda
Strategic Direction
Key Facts
Summary 37 Sanofi-Aventis Farmacêutica Ltda: Key Facts
Summary 38 Sanofi-Aventis Farmacêutica Ltda: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 39 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2009
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Data table 11 Sales of Herbal/Traditional Products: Value from 2004 to 2009
Data table 12 Sales of Herbal/Traditional Products: % Value Growth from 2004 to 2009
Data table 13 Herbal/Traditional Products Market Shares from 2005 to 2009
Data table 14 Herbal/Traditional Products Brand Shares from 2006 to 2009
Data table 15 Projection Sales of Herbal/Traditional Products: Value from 2009 to 2014
Data table 16 Projection Sales of Herbal/Traditional Products: % Value Growth from 2009 to 2014
"
